Effect of dimethylnitrosamine-induced liver dysfunction on the pharmacokinetics of 5-fluorouracil after administration of S-1, an antitumour drug, to rats.
about
Galactosylated chitosan/5-fluorouracil nanoparticles inhibit mouse hepatic cancer growth and its side effects.Pharmacokinetic changes of drugs in a rat model of liver cirrhosis induced by dimethylnitrosamine, alone and in combination with diabetes mellitus induced by streptozotocin.Entrapment of 5-fluorouracil into PLGA matrices using supercritical antisolvent processes.Species variation in the enantioselective metabolism of tegafur to 5-fluorouracil among rats, dogs and monkeys.Fabrication and Use of Poly(d,l-lactide-co-glycolide)-Based Formulations Designed for Modified Release of 5-Fluorouracil.
P2860
Effect of dimethylnitrosamine-induced liver dysfunction on the pharmacokinetics of 5-fluorouracil after administration of S-1, an antitumour drug, to rats.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Effect of dimethylnitrosamine- ...... , an antitumour drug, to rats.
@en
Effect of dimethylnitrosamine- ...... , an antitumour drug, to rats.
@nl
type
label
Effect of dimethylnitrosamine- ...... , an antitumour drug, to rats.
@en
Effect of dimethylnitrosamine- ...... , an antitumour drug, to rats.
@nl
prefLabel
Effect of dimethylnitrosamine- ...... , an antitumour drug, to rats.
@en
Effect of dimethylnitrosamine- ...... , an antitumour drug, to rats.
@nl
P2093
P2860
P356
P1476
Effect of dimethylnitrosamine- ...... , an antitumour drug, to rats.
@en
P2093
Junko Chikamoto
Kunihiro Yoshisue
Sekio Nagayama
Shohei Kanie
Takako Nishimura
P2860
P304
P356
10.1211/JPP.61.12.0009
P577
2009-12-01T00:00:00Z